US Patent 11111285 Glucagon-GLP-1-GIP triple agonist compounds

Patent 11111285 was granted and assigned to Zealand Pharma A/S on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Zealand Pharma A/S

Current Assignee

Zealand Pharma A/S

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11111285

Date of Patent

September 7, 2021

Patent Application Number

20181004

Date Filed

October 4, 2018

Patent abstract

The present invention relates to compounds which have agonist activity at the glucagon, GIP and GLP-1 receptors, and to their use in the treatment of metabolic disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11111285 Glucagon-GLP-1-GIP triple agonist compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API